‘Rise Up’ features UK spoken word poet and hip-hop artist Duke Al Durham, who also has aT1D, and is inspired by the artists’ ...

Sustainable health cannot be solved by science, clinical trial representation and access alone. It’s also down to how we live ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...

It will be a long storm to weather, but change is afoot and the future is bright Now more than ever, the sector needs bold, ...

A team of researchers from the UK Dementia Research Institute (UKDRI) are evaluating whether a new blood test can ...

Roche has shared positive new 96-week data for its investigational fenebrutinib in patients with relapsing forms of multiple ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

Sanofi has announced that it will be acquiring Vigil Neuroscience and its investigational Alzheimer’s disease (AD) drug for ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 ...

In exchange, 3SBio will receive $1.25bn upfront from Pfizer and will be eligible for certain development, regulatory and ...

Biogen and City Therapeutics have announced a partnership worth over $1bn to develop new RNAi therapies. The collaboration ...

Join us on an adventure Alex Legg is one of 15 speakers at Adventures In Pharma on 1 July in London. Join him there to ...